Maravai Lifesciences Reports First Quarter 2025 Financial Results

SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2025, together with other business updates. Financial Highlights: Quarterly revenue of $46.9 million, Net loss of$(52.9) million (including a goodwill impairment of $12.4 million), and Adjusted EBITDA of$(10.5) million; andRevenue ...